Eastern Capital Ltd - Net Worth and Insider Trading

Eastern Capital Ltd Net Worth

The estimated net worth of Eastern Capital Ltd is at least $158 Million dollars as of 2024-11-13. Eastern Capital Ltd is the 10% Owner of Cytokinetics Inc and owns about 2,383,850 shares of Cytokinetics Inc (CYTK) stock worth over $134 Million. Eastern Capital Ltd is the 10% Owner of Vericel Corp and owns about 424,988 shares of Vericel Corp (VCEL) stock worth over $24 Million. Eastern Capital Ltd is also the 10% Owner of iBio Inc and owns about 17,259 shares of iBio Inc (IBIO) stock worth over $44,010. Besides these, Eastern Capital Ltd also holds Cyclacel Pharmaceuticals Inc (CYCC) . Details can be seen in Eastern Capital Ltd's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eastern Capital Ltd has not made any transactions after 2020-08-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Eastern Capital Ltd

Eastern Capital Ltd Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eastern Capital Ltd owns 6 companies in total, including iBio Inc (IBIO) , Marker Therapeutics Inc (MRKR) , and Cyclacel Pharmaceuticals Inc (CYCC) among others .

Click here to see the complete history of Eastern Capital Ltd’s form 4 insider trades.

Insider Ownership Summary of Eastern Capital Ltd

Ticker	Comapny	Transaction Date	Type of Owner
IBIO	iBio Inc	2020-08-11	10 percent owner
MRKR	Marker Therapeutics Inc	2015-03-09	10 percent owner
CYCC	Cyclacel Pharmaceuticals Inc	2017-07-19	10 percent owner
		2015-10-30	10 percent owner
		2013-08-16	10 percent owner
		2012-06-20	10 percent owner

Eastern Capital Ltd Latest Holdings Summary

Eastern Capital Ltd currently owns a total of 4 stocks. Among these stocks, Eastern Capital Ltd owns 2,383,850 shares of Cytokinetics Inc (CYTK) as of June 20, 2012, with a value of $134 Million and a weighting of 84.91%. Eastern Capital Ltd owns 424,988 shares of Vericel Corp (VCEL) as of August 16, 2013, with a value of $24 Million and a weighting of 15.06%. Eastern Capital Ltd also owns 17,259 shares of iBio Inc (IBIO) as of August 11, 2020, with a value of $44,010 and a weighting of 0.03%. The other 1 stocks Cyclacel Pharmaceuticals Inc (CYCC) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Eastern Capital Ltd

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
CYTK	Cytokinetics Inc	2012-06-20	2,383,850	56.21	133,984,289
VCEL	Vericel Corp	2013-08-16	424,988	55.90	23,756,829
IBIO	iBio Inc	2020-08-11	17,259	2.55	44,010
CYCC	Cyclacel Pharmaceuticals Inc	2017-07-19	7,224	0.41	2,962

Holding Weightings of Eastern Capital Ltd

Eastern Capital Ltd Form 4 Trading Tracker

According to the SEC Form 4 filings, Eastern Capital Ltd has made a total of 0 transactions in Cytokinetics Inc (CYTK) over the past 5 years. The most-recent trade in Cytokinetics Inc is the sale of 0 shares on June 20, 2012, which brought Eastern Capital Ltd around $0.

According to the SEC Form 4 filings, Eastern Capital Ltd has made a total of 0 transactions in Vericel Corp (VCEL) over the past 5 years. The most-recent trade in Vericel Corp is the sale of 0 shares on August 16, 2013, which brought Eastern Capital Ltd around $0.

According to the SEC Form 4 filings, Eastern Capital Ltd has made a total of 2 transactions in iBio Inc (IBIO) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in iBio Inc is the sale of 48,970 shares on August 11, 2020, which brought Eastern Capital Ltd around $80 Million.

More details on Eastern Capital Ltd's insider transactions can be found in the Insider Trading History of Eastern Capital Ltd table.

Insider Trading History of Eastern Capital Ltd

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eastern Capital Ltd Trading Performance

GuruFocus tracks the stock performance after each of Eastern Capital Ltd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eastern Capital Ltd is 6.73%. GuruFocus also compares Eastern Capital Ltd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eastern Capital Ltd within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Eastern Capital Ltd's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Eastern Capital Ltd

Average Return

Average return per transaction

Outperforming Transactions

0 out of 5 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	3.16
Relative Return to S&P 500(%)	1.51

Eastern Capital Ltd Ownership Network

Ownership Network List of Eastern Capital Ltd

No Data

Ownership Network Relation of Eastern Capital Ltd

Eastern Capital Ltd Owned Company Details

What does iBio Inc do?

Who are the key executives at iBio Inc?

Eastern Capital Ltd is the 10 percent owner of iBio Inc. Other key executives at iBio Inc include Chief Scientific Officer Martin Brenner , Interim CFO Felipe Duran , and director & CEO and Executive Chairman Isett Thomas Francis 3rd .

iBio Inc (IBIO) Insider Trades Summary

Over the past 18 months, Eastern Capital Ltd made no insider transaction in iBio Inc (IBIO). Other recent insider transactions involving iBio Inc (IBIO) include a net sale of 75,060 shares made by Martin Brenner ,

In summary, during the past 3 months, insiders sold 0 shares of iBio Inc (IBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,753 shares of iBio Inc (IBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,753 shares.

iBio Inc (IBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

iBio Inc Insider Transactions

No Available Data

What does Marker Therapeutics Inc do?

Who are the key executives at Marker Therapeutics Inc?

Eastern Capital Ltd is the 10 percent owner of Marker Therapeutics Inc. Other key executives at Marker Therapeutics Inc include Interim CFO Eliot M Lurier , 10 percent owner Scott D Sandell , and 10 percent owner Carmen Chang .

Marker Therapeutics Inc (MRKR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Marker Therapeutics Inc (MRKR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Marker Therapeutics Inc (MRKR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Marker Therapeutics Inc (MRKR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Marker Therapeutics Inc Insider Transactions

No Available Data

What does Cyclacel Pharmaceuticals Inc do?

Who are the key executives at Cyclacel Pharmaceuticals Inc?

Eastern Capital Ltd is the 10 percent owner of Cyclacel Pharmaceuticals Inc. Other key executives at Cyclacel Pharmaceuticals Inc include director & President & C.E.O. Spiro Rombotis , director & E.V.P. & Finance & C.O.O. Paul Mcbarron , and Chief Medical Officer Mark Kirschbaum .

Cyclacel Pharmaceuticals Inc (CYCC) Insider Trades Summary

Over the past 18 months, Eastern Capital Ltd made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .

In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.

Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cyclacel Pharmaceuticals Inc Insider Transactions

No Available Data

What does Avid Bioservices Inc do?

Who are the key executives at Avid Bioservices Inc?

Eastern Capital Ltd is the 10 percent owner of Avid Bioservices Inc. Other key executives at Avid Bioservices Inc include Chief Commercial Officer Matthew R. Kwietniak , Chief Operations Officer Richard A. Richieri , and director & President & CEO Nicholas Stewart Green .

Avid Bioservices Inc (CDMO) Insider Trades Summary

Over the past 18 months, Eastern Capital Ltd made no insider transaction in Avid Bioservices Inc (CDMO). Other recent insider transactions involving Avid Bioservices Inc (CDMO) include a net sale of 10,439 shares made by Matthew R. Kwietniak , a net sale of 16,191 shares made by Richard A. Richieri , and a net sale of 104,497 shares made by Nicholas Stewart Green .

In summary, during the past 3 months, insiders sold 20,506 shares of Avid Bioservices Inc (CDMO) in total and bought 0 shares, with a net sale of 20,506 shares. During the past 18 months, 168,806 shares of Avid Bioservices Inc (CDMO) were sold and 81,803 shares were bought by its insiders, resulting in a net sale of 87,003 shares.

Avid Bioservices Inc (CDMO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avid Bioservices Inc Insider Transactions

No Available Data

What does Vericel Corp do?

Who are the key executives at Vericel Corp?

Eastern Capital Ltd is the 10 percent owner of Vericel Corp. Other key executives at Vericel Corp include director & President and CEO Dominick Colangelo , Chief Medical Officer Jonathan Mark Hopper , and SVP & General Counsel Sean C. Flynn .

Vericel Corp (VCEL) Insider Trades Summary

Over the past 18 months, Eastern Capital Ltd made no insider transaction in Vericel Corp (VCEL). Other recent insider transactions involving Vericel Corp (VCEL) include a net sale of 396,849 shares made by Dominick Colangelo , a net sale of 21,000 shares made by Zerbe Robert L Md , and a net sale of 47,768 shares made by Sean C. Flynn .

In summary, during the past 3 months, insiders sold 137,500 shares of Vericel Corp (VCEL) in total and bought 0 shares, with a net sale of 137,500 shares. During the past 18 months, 558,279 shares of Vericel Corp (VCEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 558,279 shares.

Vericel Corp (VCEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vericel Corp Insider Transactions

No Available Data

What does Cytokinetics Inc do?

Who are the key executives at Cytokinetics Inc?

Eastern Capital Ltd is the 10 percent owner of Cytokinetics Inc. Other key executives at Cytokinetics Inc include EVP & Corp. Development & CBO Robert I Blum , SVP Research & Early Dev Fady Ibraham Malik , and VP & Chief Accounting Officer Robert Wong .

Cytokinetics Inc (CYTK) Insider Trades Summary

Over the past 18 months, Eastern Capital Ltd made no insider transaction in Cytokinetics Inc (CYTK). Other recent insider transactions involving Cytokinetics Inc (CYTK) include a net sale of 351,000 shares made by Robert I Blum , a net sale of 192,307 shares made by Fady Ibraham Malik , and a net sale of 40,000 shares made by B Lynne Parshall .

In summary, during the past 3 months, insiders sold 83,336 shares of Cytokinetics Inc (CYTK) in total and bought 0 shares, with a net sale of 83,336 shares. During the past 18 months, 649,809 shares of Cytokinetics Inc (CYTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 649,809 shares.

Cytokinetics Inc (CYTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cytokinetics Inc Insider Transactions

No Available Data

Eastern Capital Ltd Mailing Address

Above is the net worth, insider trading, and ownership report for Eastern Capital Ltd. You might contact Eastern Capital Ltd via mailing address: 10 Market Street, #773, Camana Bay, Grand Cayman E9 Ky1-9006.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.